Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_assertion type Assertion NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_head.
- NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_assertion description "[Inhibitors of lipogenic signaling, including those that inhibit the AKT pathway, might be useful as therapeutics for patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_provenance.
- NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_assertion evidence source_evidence_literature NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_provenance.
- NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_assertion SIO_000772 21147110 NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_provenance.
- NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_assertion wasDerivedFrom befree-2016 NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_provenance.
- NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_assertion wasGeneratedBy ECO_0000203 NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_provenance.